Indication for aldosterone antagonist after STMI: a) Left ventricular ejection fraction (LVEF) ≤ 40% b) Heart failure symptoms despite optimal medical therapy c) Post-MI with symptomatic heart failure and reduced ejection fraction d) All of the above